Aerovate Therapeutics, Inc.(NasdaqGM:AVTE) dropped from Russell 3000E Value Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.32 USD | -2.55% | -6.89% | -15.16% |
12/04 | Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing | MT |
04/04 | Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.16% | 570M | |
+23.25% | 44.96B | |
+0.51% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+11.01% | 26.08B | |
-21.37% | 19.03B | |
+6.31% | 12.75B | |
+28.88% | 12.06B | |
-3.54% | 11.75B |
- Stock Market
- Equities
- AVTE Stock
- News Aerovate Therapeutics, Inc.
- Aerovate Therapeutics, Inc.(NasdaqGM: AVTE) dropped from Russell 3000E Value Index